Verified Treatment Center
San Francisco General Hospital Opiate Treatment Outpatient Program
San Francisco, CA · 94110
Key Takeaways for San Francisco General Hospital Opiate Treatment Outpatient Program
- • Outpatient · MAT · Dual Dx offered
- • Accepts Medicaid
- • SAMHSA-listed facility
- • Direct line available · Helpline free & confidential 24/7
About San Francisco General Hospital Opiate Treatment Outpatient Program
If you are looking at San Francisco General Hospital Opiate Treatment Outpatient Program in San Francisco, CA, the basics worth knowing up front: The facility offers a continuum of care across multiple levels — Outpatient, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. This page walks through the questions that tend to matter most to families weighing a specific program.
Care levels at San Francisco General Hospital Opiate Treatment Outpatient Program
The care-level question matters because what a facility offers is what it can realistically treat well. The facility offers a continuum of care across multiple levels — Outpatient, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether San Francisco General Hospital Opiate Treatment Outpatient Program's offerings match the clinical need.
Insurance and payment
San Francisco General Hospital Opiate Treatment Outpatient Program accepts Medicaid — which is consequential because facilities that accept Medicaid tend to have the broadest patient populations and the most developed public-sector relationships, though reimbursement structures mean program intensity sometimes differs from commercial-focused centers. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.
Specialty programming
The facility's documented specialty programming includes: Pregnant/postpartum women, Clients with HIV or AIDS. If that matches what you or your family member need, great — and worth asking specifically about what the programming looks like day-to-day (how many hours per week of specialty-specific content, who leads it, what credentials they hold).
Before you call
Before admission to San Francisco General Hospital Opiate Treatment Outpatient Program, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.
Listing sourced from the SAMHSA Behavioral Health Treatment Services Locator. Data last synced April 2026. Verify current programs directly with the facility.
San Francisco General Hospital Opiate Treatment Outpatient Program at a Glance
Levels of care
Outpatient · MAT · Dual Dx
Service settings
Outpatient, Outpatient methadone/buprenorphine or naltrexone treatment
Therapy approaches
Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Relapse prevention, Substance use disorder counseling
Age groups
Young Adults, Adults
Special populations
Pregnant/postpartum women, Clients with HIV or AIDS
Medications
Acamprosate (Campral®), Disulfiram, Methadone, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable)
Insurance & Payment Accepted
Confirm in-network status before admission — verification is free.
Contact & Location
Address
1001 Potrero Avenue, San Francisco, CA 94110
Facility direct line
628-206-8412Website
dsaam.org